Ling Su - Profile and Investment Details
Find investors who align with your industry, stage, and vision. Unlock Ling Su’s full investment profile, including location, investment focus, portfolio companies, and preferences. Sign up today and start building investor relationships that fuel your startup’s growth.
Get connected with all investors today
fir***@***.com Available after registration.
Markets
Past investmentsLing Su is a Venture Capital based in Shanghai, China with a diverse investment portfolio that includes companies such as KSQ Therapeutics, Sidley Austin LLP, xInnovent Biologics, Abbisko Therapeutics, Microtech Medical, Metacrine, ImmuneOnco Biopharma, Targeting One, Alector, Hangzhou Just Biotherapeutics (Just China), Fortis Therapeutics, Harpoon Therapeutics, Legend Biotech, Elpiscience Biopharmaceuticals, Ansun BioPharma, Geneseeq, Turning Point Therapeutics, ReadCoor, dMed, Singlera Genomics, DIA, Singleron Biotechnologies, IMPACT Therapeutics, Nucleix, GeneceptionNuVera Medical, CARsgen Therapeutics, Just - Evotec Biologics, Terns Pharmaceuticals, Tmunity Therapeutics, 360 Health, Transcenta, NextCure, Nuohui Health, Regor Therapeutics, Merck, InventisBio, EdiGene, Tempest Therapeutics, Gracell Biotechnologies, Sonoma BioTherapeutics, NiKang Therapeutics, Inhibrx, Rongchang Pharmaceutical, Remegen, Mailing Yiliao, Magnolia NeuroSciences, Burning Rock Biotech, Passage Bio, Fountain Medical Development, CanSinoBIO, MabSpace Biosciences, Sansure Biotech, NovoCodex, Gritstone Oncology, Veritas Genetics, ACEA BIO, Peijia Medical, Insilico Medicine, Jacobio Pharmaceuticals, Avedro, 360 Haoyao, Dizal Pharma, Roche, Connect Biopharmaceuticals, Qihan Biotech, Ionova Life Science, . Over time, Ling Su has demonstrated experience in supporting a range of businesses across various sectors.
While it is not publicly confirmed whether Ling Su is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.
Startups and entrepreneurs operating in sectors related to Health Care, Genetics, Women Founded, Life Science, Robotics, Information Technology (IT), Manufacturing, Biotechnology, Genomics, Health Diagnostics, Medical, Therapeutics, Personal Health, Pharmaceuticals may find it worthwhile to explore potential connections with Ling Su, as their portfolio suggests a familiarity and interest in this area.
Understanding Ling Su’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.
